Quantitative analysis of estrogen receptor alpha and beta messenger ribonucleic acid levels in normal endometrium and ovarian endometriotic cysts using a real-time reverse transcription-polymerase chain reaction assay

Fertil Steril. 2000 Oct;74(4):753-9. doi: 10.1016/s0015-0282(00)00712-3.

Abstract

Objective: To quantify messenger RNA (mRNA) levels of the two estrogen receptor isoforms, estrogen receptor-alpha (ER-alpha) and estrogen receptor-beta (ER-beta) in the eutopic endometrium and ovarian endometriotic cysts.

Design: Prospective study.

Setting: University hospital.

Patient(s): Patients with endometriosis and patients with uterine leiomyoma or carcinoma in situ.

Intervention(s): Gonadotropin-releasing hormone agonist (GnRH-a)-treated (n = 12) or untreated (n = 24) endometriotic cysts were obtained from 36 patients during laparoscopic cystectomy. Eutopic endometrium tissues were obtained from 24 patients during or immediately after surgery.

Main outcome measure(s): ER-alpha and ER-beta mRNA levels, using a real-time reverse transcription (RT)-polymerase chain reaction (PCR) assay, TaqMan RT-PCR.

Result(s): Eutopic endometrium and ovarian endometriotic cysts showed predominantly higher levels of ER-alpha mRNA than ER-beta mRNA. Although ER-alpha and ER-beta mRNA levels in the eutopic endometrium were affected by a cyclic change in ovarian hormones, ovarian endometriotic cysts were less affected. Moreover, a long-term hypoestrogenic state induced by GnRH-a especially decreased ER-alpha mRNA levels in endometriotic cysts. Consequently, the relative ratios of ER-alpha to ER-beta mRNA levels in both GnRH-a-treated and untreated endometriotic cysts were significantly lower than those in the eutopic endometrium.

Conclusion(s): The results suggest that the principal and regulatory effects of estrogens may be mediated mainly via ER-alpha rather than ER-beta in both the eutopic endometrium and endometriotic cysts.

MeSH terms

  • Adult
  • Delayed-Action Preparations
  • Endometriosis / drug therapy
  • Endometriosis / metabolism*
  • Endometrium / metabolism*
  • Estrogen Receptor alpha
  • Estrogen Receptor beta
  • Female
  • Humans
  • Leuprolide / administration & dosage
  • Leuprolide / therapeutic use
  • Ovary / metabolism*
  • Prospective Studies
  • RNA, Messenger / metabolism*
  • Receptors, Estrogen / analysis*
  • Receptors, Estrogen / genetics
  • Reverse Transcriptase Polymerase Chain Reaction

Substances

  • Delayed-Action Preparations
  • Estrogen Receptor alpha
  • Estrogen Receptor beta
  • RNA, Messenger
  • Receptors, Estrogen
  • Leuprolide